Connect with us
In 2020, this market reached $ 21.6 billion worldwide. Investment in telemedicine reached $ 4.3 billion, an increase of 139% over the previous year. Some 3.6...
Biocross, founded in 2005 as a spin-off of the Spanish National Research Council (CSIC), develops in-vitro diagnostic systems with multiple applications in prevention, clinical research, early...
The company has offices in Madrid, Barcelona and Mexico, the latter covering several Latin American countries. To date, iDoctus has invested $5.9 million (€5 million) in...
This summer, Exheus has received an Enisa loan amounting to $236,000 (€200,000). This is a long-term loan issued by the Ministry and offers extended repayment and...
ExeVir is a spin-off of VIB and is headed by German Dr. Torsten Mummenbrauer, a virologist who has worked for GSK Morphosys, Hookipa Pharma and Velvio....
Valneva will soon be able to sell its Covid-19 vaccine candidate. On the European side, Valneva has broken off negotiations with the European Commission, preferring bilateral...
Gilead's peak revenue in Spain was in 2015 when the company had a turnover $1.15 billion (€978.5 million). Those figures were due to the commercialization of...
Incliva participates in the $6.2 million (€5.2 million) European Rebecca project to address the post-treatment of breast cancer. The project will end in March 2025 and...
Grifols, which specializes in the production of plasma derivatives, achieved a profit of $317.2 million (€266.8 million) in the first half of 2021, which translates into...
The Spanish pharmaceutical company Rovi achieved a net profit of $60.3 million (€51 million) from January to June, compared to $35 million (€29.6 million) a year...